Literature DB >> 17245371

Taking the time to study competitive antagonism.

D J A Wyllie1, P E Chen.   

Abstract

Selective receptor antagonists are one of the most powerful resources in a pharmacologist's toolkit and are essential for the identification and classification of receptor subtypes and dissecting their roles in normal and abnormal body function. However, when the actions of antagonists are measured inappropriately and misleading results are reported, confusion and wrong interpretations ensue. This article gives a general overview of Schild analysis and the method of determining antagonist equilibrium constants. We demonstrate why this technique is preferable in the study of competitive receptor antagonism than the calculation of antagonist concentration that inhibit agonist-evoked responses by 50%. In addition we show how the use of Schild analysis can provide information on the outcome of single amino acid mutations in structure-function studies of receptors. Finally, we illustrate the need for caution when studying the effects of potent antagonists on synaptic transmission where the timescale of events under investigation is such that ligands and receptors never reach steady-state occupancy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245371      PMCID: PMC2189774          DOI: 10.1038/sj.bjp.0706997

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor.

Authors:  Bodo Laube; Rudolf Schemm; Heinrich Betz
Journal:  Neuropharmacology       Date:  2004-12       Impact factor: 5.250

2.  The receptor concept: pharmacology's big idea.

Authors:  H P Rang
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

3.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

4.  Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations.

Authors:  S Lazareno; N J Birdsall
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

5.  Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.

Authors:  Philip E Chen; Matthew T Geballe; Phillip J Stansfeld; Alexander R Johnston; Hongjie Yuan; Amanda L Jacob; James P Snyder; Stephen F Traynelis; David J A Wyllie
Journal:  Mol Pharmacol       Date:  2005-02-09       Impact factor: 4.436

6.  Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles.

Authors:  Kevin Erreger; Shashank M Dravid; Tue G Banke; David J A Wyllie; Stephen F Traynelis
Journal:  J Physiol       Date:  2005-01-13       Impact factor: 5.182

7.  Identification of subunit- and antagonist-specific amino acid residues in the N-Methyl-D-aspartate receptor glutamate-binding pocket.

Authors:  Leo Kinarsky; Bihua Feng; Donald A Skifter; Richard M Morley; Simon Sherman; David E Jane; Daniel T Monaghan
Journal:  J Pharmacol Exp Ther       Date:  2005-03-02       Impact factor: 4.030

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

Review 9.  Pharmacological insights obtained from structure-function studies of ionotropic glutamate receptors.

Authors:  Philip E Chen; David J A Wyllie
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

10.  Single-channel analysis of a point mutation of a conserved serine residue in the S2 ligand-binding domain of the NR2A NMDA receptor subunit.

Authors:  David J A Wyllie; Alexander R Johnston; Diane Lipscombe; Philip E Chen
Journal:  J Physiol       Date:  2006-05-18       Impact factor: 5.182

View more
  45 in total

1.  Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses.

Authors:  Peng Xia; Huei-sheng Vincent Chen; Dongxian Zhang; Stuart A Lipton
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

2.  Creating an α7 nicotinic acetylcholine recognition domain from the acetylcholine-binding protein: crystallographic and ligand selectivity analyses.

Authors:  Akos Nemecz; Palmer Taylor
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

3.  Predicting the Activation of the Androgen Receptor by Mixtures of Ligands Using Generalized Concentration Addition.

Authors:  Jennifer J Schlezinger; Wendy Heiger-Bernays; Thomas F Webster
Journal:  Toxicol Sci       Date:  2020-10-01       Impact factor: 4.849

4.  Two Janus Cannabinoids That Are Both CB2 Agonists and CB1 Antagonists.

Authors:  Amey Dhopeshwarkar; Natalia Murataeva; Alex Makriyannis; Alex Straiker; Ken Mackie
Journal:  J Pharmacol Exp Ther       Date:  2016-12-07       Impact factor: 4.030

5.  MHC-I peptide binding activity assessed by exchange after cleavage of peptide covalently linked to β2-microglobulin.

Authors:  Mollie M Jurewicz; Richard A Willis; Vasanthi Ramachandiran; John D Altman; Lawrence J Stern
Journal:  Anal Biochem       Date:  2019-06-13       Impact factor: 3.365

6.  A triad of residues is functionally transferrable between 5-HT3 serotonin receptors and nicotinic acetylcholine receptors.

Authors:  Richard Mosesso; Dennis A Dougherty
Journal:  J Biol Chem       Date:  2018-01-03       Impact factor: 5.157

7.  Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-D-aspartate receptors.

Authors:  Kasper B Hansen; Nami Tajima; Rune Risgaard; Riley E Perszyk; Lars Jørgensen; Katie M Vance; Kevin K Ogden; Rasmus P Clausen; Hiro Furukawa; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2013-04-26       Impact factor: 4.436

8.  Distinct Signaling Patterns of Allosteric Antagonism at the P2Y1 Receptor.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Mol Pharmacol       Date:  2017-09-01       Impact factor: 4.436

9.  Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors.

Authors:  Neal Innocent; Phil D Livingstone; Arik Hone; Atsuko Kimura; Tracey Young; Paul Whiteaker; J Michael McIntosh; Susan Wonnacott
Journal:  J Pharmacol Exp Ther       Date:  2008-07-29       Impact factor: 4.030

10.  Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.

Authors:  Dinesh C Indurthi; Elena Pera; Hye-Lim Kim; Cindy Chu; Malcolm D McLeod; J Michael McIntosh; Nathan L Absalom; Mary Chebib
Journal:  Biochem Pharmacol       Date:  2014-02-15       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.